Search / Trial NCT06231238

Balance Acceptance and Commitment Therapy for Long COVID

Launched by KING'S COLLEGE LONDON · Jan 29, 2024

Trial Information

Current as of October 08, 2024

Not yet recruiting

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age 18 or older
  • 2. LC/PCS diagnosis as defined by National Health Service (NHS) / National Institute for Health and Care Excellence (NICE) (i.e., symptoms that develop during or after an infection consistent with COVID-19, continue for more than 12 weeks and are not explained by an alternative diagnosis). A checklist will be used to ensure participants fulfil the diagnostic criteria as per the NICE guidelines
  • 3. Ability to travel to the research site for the study assessments
  • 4. Consent to wear a smartwatch throughout the study
  • 5. Having registered with a General Practitioner (GP) in the United Kingdom (UK) and consent to provide their details for the study team to contact
  • 6. Ability to provide informed consent
  • 7. Ability to read and write English
  • Exclusion Criteria:
  • 1. Current diagnosis of an active major mental health disorder likely to interfere with participation
  • 2. Unstable alcohol / drug dependency
  • 3. Unstable complications associated with LC/PCS
  • 4. Past hospitalisation for COVID-19
  • 5. Current or recent participation in other treatment intervention studies (\<4 weeks after completion)
  • 6. Currently receiving psychological support or psychotherapy
  • 7. Implanted medical devices (ie., Pacemaker/defibrillator or implanted neurostimulator/infusion device; implanted metal objects; artificial hip/knee replacement, spinal surgery; cardiac surgery requiring the placement of metal clips, valves or wires)
  • 8. Pregnancy

About King's College London

King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0